Noah Knauf joined Kleiner Perkins in 2016 and focuses on investments in the firm’s digital growth practice, targeting high-growth consumer and enterprise Internet companies that have achieved strong adoption and scale.
Before joining Kleiner Perkins, Noah worked for nine years at Warburg Pincus, where he led investments in technology-enabled businesses and helped deploy $1.8 billion of equity capital across 18 companies. His investments ranged from early-stage companies to large growing enterprises with thousands of employees. Noah also led the firm’s successful investments in Constitution Medical (acquired by Roche), Lutonix (acquired by Bard), and JHP Pharmaceuticals (acquired by Par). He recently led the formation of Helix, a partnership with Illumina to build a digital consumer genomics platform.
Noah served on the boards of innovative companies such as Outset Medical, Specialists On Call, ComplexCare Solutions, Silk Road Medical, Accriva Diagnostics, and Singular Bio. Earlier in his career, Noah was an investor at Parthenon Capital and a consultant at Bain & Company.
Noah received a B.S.B.A in Management Information Systems and Operations Management from the University of Arizona and an M.B.A. from Stanford University’s Graduate School of Business, where he was an Arjay Miller Scholar.
- Consumers' Front Door to their DNA at Home and Work - Tuesday, May 8, 4:10pm-4:50pm